Early research (Phase 1)Study completedNCT00674856What this trial is testingA Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal FunctionWho this might be right forRenal Failure NicOx 32
Early research (Phase 1)Study completedNCT03951402What this trial is testingEffect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and WomenWho this might be right forProlonged QTc IntervalPharmacokinetic Grünenthal GmbH 48
Early research (Phase 1)Study completedNCT00882570What this trial is testingTo Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting ConditionsWho this might be right forHealthy Sandoz 40
Early research (Phase 1)Study completedNCT02262546What this trial is testingInfluence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female VolunteersWho this might be right forHealthy Boehringer Ingelheim 60
Testing effectiveness (Phase 2)Looking for participantsNCT07317544What this trial is testingStudy of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic AlopeciaWho this might be right forAndrogenetic Alopecia (AGA)Healthy Volunteers - Male and Female Absci Pty Ltd. 227
Early research (Phase 1)Study completedNCT06698575What this trial is testingAssess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital HerpesWho this might be right forRecurrent Genital Herpes Simplex Type 2 Assembly Biosciences 103
Early research (Phase 1)Study completedNCT02182375What this trial is testingEffect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy VolunteersWho this might be right forHealthy Boehringer Ingelheim 24
Early research (Phase 1)Study completedNCT05427253What this trial is testingFirst-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy SubjectsWho this might be right forSafety IssuesToleranceIdiopathic Pulmonary Fibrosis+1 more Vicore Pharma AB 80
Early research (Phase 1)Study completedNCT01537172What this trial is testingA Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy VolunteersWho this might be right forHealthy Adult Subjects Ono Pharmaceutical Co., Ltd. 80
Early research (Phase 1)Study completedNCT01975337What this trial is testingPharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy SubjectsWho this might be right forKidney Failure, Chronic Debiopharm International SA 16
Early research (Phase 1)Study completedNCT00970775What this trial is testingAZD2423 Single Ascending Dose Study in Healthy Japanese SubjectsWho this might be right forHealthy Volunteer AstraZeneca 32
Early research (Phase 1)Study completedNCT04364464What this trial is testingStudy on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and WeightWho this might be right forClinical Pharmacology Bayer 40
Early research (Phase 1)Study completedNCT05918588What this trial is testingDetermine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopausal Female SubjectsWho this might be right forImmune System Disorder (Healthy Volunteer) Kadmon, a Sanofi Company 32
Early research (Phase 1)Study completedNCT00715702What this trial is testingSafety Study of AZD5672 in Renally Impaired SubjectsWho this might be right forRenal Impairment AstraZeneca 40
Early research (Phase 1)Study completedNCT04004195What this trial is testingStudy to Investigate Safety, Absorption, Elimination, and Drug Effect of BAY2327949 in Participants With Different Renal Function StatusWho this might be right forPharmacokinetics Bayer 32
Early research (Phase 1)Study completedNCT00834275What this trial is testingCefadroxil 500 mg Capsules Under Fasting ConditionsWho this might be right forHealthy Teva Pharmaceuticals USA 26
Early research (Phase 1)Study completedNCT01655056What this trial is testingEvaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the BodyWho this might be right forPharmacokineticsPharmacodynamicsHealthy Subjects+2 more Astellas Pharma Europe B.V. 82
Early research (Phase 1)Study completedNCT04734275What this trial is testingStudy to Assess Relative Bioavailability and Safety of AZD5718 in Healthy VolunteersWho this might be right forChronic Kidney Disease AstraZeneca 16
Early research (Phase 1)Not Yet RecruitingNCT07793929What this trial is testingEvaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of RibupatideWho this might be right forEnd Stage Renal DiseaseRenal ImpairmentObesity+1 more Kailera 32
Early research (Phase 1)Study completedNCT00886067What this trial is testingPositron Emission Tomography (PET) StudyWho this might be right forHealthy AstraZeneca 11